Skip to main content

PROVINCIAL DRUG COVERAGE – Prince Edward Island

AS OF January 2025

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

PRINCE EDWARD ISLAND COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit (10mg, 70mg); Non-Benefit (5mg)

Fosavance; Generics Available

Regular Benefit (70 mg/5600 IU);
Non-Benefit (70 mg/2800 IU)

Risedronate

Actonel; Generics Available

Regular Benefit (5 mg Generics, All 35mg); Limited Coverage (30mg Generics); Non-Benefit (All 150mg)

Actonel; DR

Non-Benefit

Zoledronic Acid

Aclasta; Generics Available

Regular Benefit (5mg inj); Non-Benefit (4mg inj)

SERMs

Raloxifene

Evista; Generics Available

Regular Benefit (Generics Only)

Teriparatide (PTH)

Forteo; Generics Available

Non-Benefit

Osnuvo (biosimilar)

Non-Benefit

Denosumab

Prolia

Limited Coverage

Jubbonti (biosimilar)

Non-Benefit

Romosozumab

Evenity

Non-Benefit

© Osteoporosis Canada, 2025
Charitable Registration No. 89551 0931 RR 0001